Paraskevas Kosmidis

Paclitaxel and carboplatin as first-line chemotherapy combined with gefitinib (IRESSA) in patients with advanced breast cancer: a phase I/II study conducted by the Hellenic Cooperative Oncology Group

George Fountzilas, Dimitrios Pectasides, Anna Kalogera‐Fountzila et al. · Breast Cancer Research and Treatment · 2005 · 37 citations

Medicine, Oncology, Pharmacology +9

Comprehensive tumor molecular profile analysis in clinical practice

Mustafa Özdoğan, Eirini Papadopoulou, Aikaterini Tsantikidi et al. · BMC Medical Genomics · 2021 · 27 citations · Full text

Medicine, Molecular Medicine, Oncology +17

Evaluation of the prognostic role of a panel of biomarkers in stage IB-IIIA non-small cell lung cancer patients.

Eleni Timotheadou, D. Skarlos, E. Samantas et al. · PubMed · 2008 · 20 citations

Medicine, Oncology, Radiation Oncology +15

Three‐Dimensional Conformal Radiotherapy for Hepatocellular Carcinoma in Patients Unfit for Resection, Ablation, or Chemotherapy: A Retrospective Study

Vassilis Kouloulias, Eftychia Mosa, Kalliopi Platoni et al. · The Scientific World JOURNAL · 2013 · 18 citations · Full text

Medicine, Oncology, Surgery +15

Docetaxel and gemcitabine combination, as first-line treatment, in patients with extensive disease small-cell lung cancer. A phase II study of the Hellenic Cooperative Oncology Group

D. Skarlos, Meletios Α. Dimopoulos, Paraskevas Kosmidis et al. · Lung Cancer · 2003 · 17 citations

Medicine, Oncology, Pharmacology +12